I am a board-certified abdominal radiologist and medical ultrasound researcher with over 15 years of experience in developing and applying innovative ultrasound technologies to enhance patient care. At the University of Michigan (UM) Hospital, I am one of three body interventional radiologists specializing in the treatment of liver tumors using histotripsy. As the Director of Abdominal Ultrasound, I established and have been leading the clinical contrast-enhanced ultrasound (CEUS) service, focusing on the diagnosis of liver and kidney tumors and advancing translational and clinical CEUS research. During my PhD and post-doctoral training, I significantly contributed to the development of sonoelastography, an ultrasound elasticity imaging technique for tumor detection, and played a key role in advancing the acoustic droplet vaporization technique, which induces hypoxemia in target tissues, holding the potential for cancer therapy. My recent research interests include developing quantitative imaging biomarkers for the diagnosis of severe peripheral arterial disease and the evaluation of uterine cervical diseases, projects that have been supported by internal and societal awards. Over the past four years, I have been focusing on the histotripsy ablation for orthotopic liver tumors in an in vivo metastatic rodent model, employing machine learning and AI tools to enhance the pre- and post-treatment imaging surveillance.
Two of my most interesting projects :
- Shear wave elastography (SWE) in assessment of human ovarian stiffness and reproductive longevity, and uterine cervical stiffness in preterm labor and outcome of labor induction.
- Quantify histotripsy treatment outcomes using multiparametric ultrasound imaging
I am eager to facilitate the transition from scientific research to clinical application, enhancing patient care in the process.
I believe that data science and AI research will significantly advance imaging science, ultimately leading to substantial improvements in patient care.